MOTS-c
aka Mitochondrial Open reading frame of the Twelve S rRNA type-c
GLP-1 / Metabolic
Mechanism
MOTS-c is an investigational mitochondrial-derived peptide studied preclinically for metabolic regulation. It is research-only and not FDA-approved; the CB4211 analog program (CohBar) was discontinued in 2023.
Identification
Vendors selling MOTS-c
No vendor listings on file yet.
Research
No citations on file yet.